Hypoxia-induced histone lactylation promotes pulmonary arterial smooth muscle cells proliferation in pulmonary hypertension
Open Access
- 30 June 2025
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 480 (11) , 5685-5697
Abstract
Pulmonary hypertension (PH) is characterized by pulmonary vascular remodeling and excessive proliferation of pulmonary artery smooth muscle cells (PASMCs). Glycolysis plays a crucial role in PH pathogenesis, but the epigenetic mechanisms linking glycolysis to PASMCs proliferation remain unclear. Histone lactylation, a novel post-translational modification derived from glycolytic lactate, may regulate PASMCs proliferation. Primary rat PASMCs were cultured under hypoxia and treated with sodium L-lactate (NaLa) to assess glycolytic activity and histone lactylation. RNA sequencing, RT-qPCR, and Western blotting identified differentially expressed genes (DEGs), while ChIP-qPCR evaluated histone lactylation enrichment at gene promoters. In vivo, a hypoxia-induced PH rat model was used to examine the effect of glycolysis inhibition using oxamate. Mendelian randomization (MR) analysis assessed the causal relationship between placental growth factor (PGF) and PH. Hypoxia and NaLa treatment significantly increased glycolytic activity, lactate production, and histone lactylation, promoting PASMCs proliferation. Transcriptomic analysis identified 157 DEGs, with five key genes (Gbe1, Pgf, Mt2A, Ythdf2 and Gys1) upregulated in response to histone lactylation. ChIP-qPCR confirmed H3K18la enrichment at their promoters. Glycolysis inhibition with oxamate effectively reduced histone lactylation, PASMCs proliferation, and vascular remodeling in hypoxic PH rats. MR analysis identified PGF as a causal factor contributing to PH risk, suggesting a potential therapeutic target. This study reveals that glycolysis-induced histone lactylation drives PASMCs proliferation and vascular remodeling in PH. Targeting lactate metabolism and histone lactylation may provide a novel therapeutic approach.Keywords
Funding Information
- Scientific research funding for the introduction of talents by the First Affiliated Hospital of Fujian Medical University (YJRC4183)
- Joint Funds for the Innovation of Science and Technology, Fujian province (2020Y9108)
- National Natural Science Foundation of China under Grant (82370351)
This publication has 34 references indexed in Scilit:
- Lactate and lactylation in cancerSignal Transduction and Targeted Therapy, 2025
- Challenges and opportunities in targeting epigenetic mechanisms for pulmonary arterial hypertension treatmentInternational Journal of Pharmaceutics, 2025
- TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosisCell Death Discovery, 2023
- Immunolocalization of zinc transporters and metallothioneins reveals links to microvascular morphology and functionsHistochemistry and Cell Biology, 2022
- The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertensionLife Sciences, 2021
- VEGFR1 signaling in retinal angiogenesis and microinflammationProgress in Retinal and Eye Research, 2021
- Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cellsPulmonary Pharmacology & Therapeutics, 2020
- Endothelial Lactate Controls Muscle Regeneration from Ischemia by Inducing M2-like Macrophage PolarizationCell Metabolism, 2020
- Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinomaSignal Transduction and Targeted Therapy, 2020
- Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenonPharmacology & Therapeutics, 2020